Featured Research

from universities, journals, and other organizations

African HIV Strains Appear More Resistant To Current Therapies

Date:
July 4, 2002
Source:
American Chemical Society
Summary:
Of the 40 million people infected worldwide with HIV, more than 70 percent live in Africa. Yet a new study suggests a key component in current therapies could be less effective on African forms of the virus. The findings are reported in the July 9 print issue of Biochemistry, a peer-reviewed journal of the American Chemical Society, the world's largest scientific society.

Of the 40 million people infected worldwide with HIV, more than 70 percent live in Africa. Yet a new study suggests a key component in current therapies could be less effective on African forms of the virus. The findings are reported in the July 9 print issue of Biochemistry, a peer-reviewed journal of the American Chemical Society, the world's largest scientific society.

"Although clinical studies are still very limited, early reports in the medical literature have suggested a poorer long-term response to antiviral therapies in African patients, despite a similar initial response," said Ernesto Freire, Ph.D., professor of biology and biophysics at Johns Hopkins University and lead author of the paper.

One proposed explanation for the response has been patients' inability to adhere to the strict regimen required by antiretroviral drugs. But the new studies also suggest a molecular basis might be present.

HIV's shape-shifting nature has helped it reach epidemic proportions. The virus constantly morphs, causing drug resistance and geographical variations. For example, the HIV-B subtype predominates in Western Europe and the United States, while genetically different strains — HIV-A and HIV-C — occur mostly in Africa. Currently available therapies have been designed specifically for the B subtype, Freire said, but now may need to be tailored for the African subtypes.

Some of the most effective weapons in the fight against HIV infection are protease inhibitors. These compounds are not AIDS vaccines, but can reduce the spread of the disease by binding to the HIV protease — a key protein in the reproductive cycle of the virus.

In their study, the researchers introduced into the C and A proteases a common B-subtype mutation that could potentially be seen in African forms of the virus. The mutations, known to cause drug resistance in the B-subtype, enhance the biochemical "fitness" of the protease, making it better able to survive in the presence of HIV drugs.

The researchers found that the fitness of the C and A mutant proteases can be up to 1000-fold higher than that of the normal B subtype — a significant increase over results from a previous study, where they reported that natural differences alone were responsible for increasing the biochemical fitness by a factor of 2-7.

"In other words," Freire explained, "the natural variations that exist in the protease of these African strains are not sufficient to cause resistance by themselves, but they amplify the effects of drug resistant mutations and, hence, may lead to a faster long-term failure of the therapy."

The research supports the argument that scientists need to broaden the focus of HIV drug development, which has been almost exclusively centered on HIV-B. However, Freire cautioned, "The experiments so far are at the biochemical level and a direct translation to a clinical response is not straightforward."

In the meantime, the findings do not justify withholding existing therapies from patients infected with African subtypes, Freire added. On the contrary: they emphasize the need to use existing therapies aggressively to suppress the emergence of mutations that cause drug resistance.


Story Source:

The above story is based on materials provided by American Chemical Society. Note: Materials may be edited for content and length.


Cite This Page:

American Chemical Society. "African HIV Strains Appear More Resistant To Current Therapies." ScienceDaily. ScienceDaily, 4 July 2002. <www.sciencedaily.com/releases/2002/07/020704084006.htm>.
American Chemical Society. (2002, July 4). African HIV Strains Appear More Resistant To Current Therapies. ScienceDaily. Retrieved September 30, 2014 from www.sciencedaily.com/releases/2002/07/020704084006.htm
American Chemical Society. "African HIV Strains Appear More Resistant To Current Therapies." ScienceDaily. www.sciencedaily.com/releases/2002/07/020704084006.htm (accessed September 30, 2014).

Share This



More Health & Medicine News

Tuesday, September 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

How 'Yes Means Yes' Defines Sexual Assault

How 'Yes Means Yes' Defines Sexual Assault

Newsy (Sep. 29, 2014) Aimed at reducing sexual assaults on college campuses, California has adopted a new law changing the standard of consent for sexual activity. Video provided by Newsy
Powered by NewsLook.com
Scientists May Have Found An Early Sign Of Pancreatic Cancer

Scientists May Have Found An Early Sign Of Pancreatic Cancer

Newsy (Sep. 29, 2014) Researchers looked at 1,500 blood samples and determined people who developed pancreatic cancer had more branched chain amino acids. Video provided by Newsy
Powered by NewsLook.com
Colo. Doctors See Cluster of Enterovirus Cases

Colo. Doctors See Cluster of Enterovirus Cases

AP (Sep. 29, 2014) Doctors at the Children's Hospital of Colorado say they have treated over 4,000 children with serious respiratory illnesses since August. Nine of the patients have shown distinct neurological symptoms, including limb weakness. (Sept. 29) Video provided by AP
Powered by NewsLook.com
Dr.'s Unsure of Cause of Fast-Spreading Virus

Dr.'s Unsure of Cause of Fast-Spreading Virus

AP (Sep. 29, 2014) Doctors at the Children's Hospital of Colorado say they have treated over 4,000 children with serious respiratory illnesses since August. Nine of the patients have shown distinct neurological symptoms, including limb weakness. (Sept. 29) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins